最新の財務諸表(Form-10K)によると、AddLife AB (publ)の総資産は$12,711で、純利益は$560です。
ADDLFの主要な財務比率は何ですか?
AddLife AB (publ)の流動比率は1.74、純利益率は5.36、1株当たり売上高は$85.68です。
AddLife AB (publ)の収益はセグメントまたは地域別にどのように分けられていますか?
AddLife AB (publ) の最大収益セグメントは MedTech で、最新の利益発表における収益は 6,042,000,000 です。地域別に見ると、Other Countries が AddLife AB (publ) の主要市場であり、収益は 2,914,000,000 です。
AddLife AB (publ)は収益を上げていますか?
はい、最新の財務諸表によると、AddLife AB (publ)の純利益は$560です。
AddLife AB (publ)に負債はありますか?
はい、AddLife AB (publ)の負債は7,268です。
AddLife AB (publ)の発行済株式数は何株ですか?
AddLife AB (publ)の総発行済株式数は121.86株です。
主要データ
前終値
$42
始値
$42
当日レンジ
$7.94 - $42
52週レンジ
$7.94 - $42
取引高
3.0K
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
0.68
時価総額
$4.9B
ADDLIFE ABとは何ですか?
AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.